Vimarsana
Biggest News Aggregation in the World

Page 16 - License Application News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from License Application. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In License Application Today - Breaking & Trending Today

SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Y-mAbs Therapeutics, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of March 20, 2023 - Vimarsana News

SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Y-mAbs Therapeutics, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of March 20, 2023

/PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Y-mAbs Therapeutics, Inc.. Shareholders who purchased shares of YMAB during...

BioArctic: Biologics License Application for lecanemab designated for Priority Review by China National Medical Products Administration - Vimarsana News

BioArctic: Biologics License Application for lecanemab designated for Priority Review by China National Medical Products Administration

STOCKHOLM, Feb. 28, 2023 /PRNewswire/ -- BioArctic AB's (publ) (Nasdaq Stockholm: BIOA B) partner Eisai announced today that the Biologics License Application (BLA) for lecanemab (brand name

Biologics License Application for lecanemab designated for Priority Review by China National Medical Products Administration - Vimarsana News

Biologics License Application for lecanemab designated for Priority Review by China National Medical Products Administration

/PRNewswire/ -- BioArctic AB's (publ) (Nasdaq Stockholm: BIOA B) partner Eisai announced today that the Biologics License Application (BLA) for lecanemab...

SHINE's Final Safety Evaluation Report Related to the Operating License Application Issued By NRC - Vimarsana News

SHINE's Final Safety Evaluation Report Related to the Operating License Application Issued By NRC

/PRNewswire/ -- SHINE Technologies, LLC, a next-generation fusion technology company, today announced that the U.S. Nuclear Regulatory Commission (NRC) has...

Mesoblast Reports Operational and Financial Highlights for - Vimarsana News

Mesoblast Reports Operational and Financial Highlights for

NEW YORK, Feb. 27, 2023 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory...